All Articles tagged systemic anaplastic large cell lymphoma
- Oncology
October 26, 2016 EDT To evaluate the cost-effectiveness of brentuximab vedotin in patients with R/R sALCL from a UK NHS perspective.
To evaluate the cost-effectiveness of brentuximab vedotin in patients with R/R sALCL from a UK NHS perspective.